O'Connor William, Arshia Asma, Prabakar Deipthan, Sabesan Vaishnavi, Spindel Jeffrey F
Department of Pathology and Laboratory Medicine, University of Kentucky, 800 Rose Street, Lexington, KY 40536-0298, USA.
Government Kilpauk Medical College, 822 Poonamallee High Road, Kilpauk, Chennai 600010, India.
Eur Heart J Case Rep. 2024 Aug 8;8(8):ytae412. doi: 10.1093/ehjcr/ytae412. eCollection 2024 Aug.
Lamin A/C gene (LMNA) mutations cause myocardial fibrosis manifesting as arrhythmogenic, non-compaction, or dilated cardiomyopathies. Fibro-fatty replacement largely involves the conduction system and conduction disease commonly occurs prior to contractile dysfunction.
Two young, unrelated Caucasian males, aged 34 and 25, were referred to our centre for treatment of advanced heart failure. Both patients had a family history of heart failure and sudden cardiac death among their first-degree relatives and were diagnosed with Lamin A/C mutations, but they had not been screened prior to disease onset. Although the initial phenotypes were dilated cardiomyopathy and left ventricular non-compaction cardiomyopathy, both patients' disease progressed rapidly to include ventricular arrhythmias, severe global left ventricular hypokinesis, and dependence on outpatient milrinone to complete activities of daily living. Both patients received heart transplantation within 2 years of initial disease onset. The surgical pathology of the explanted hearts revealed characteristic findings of fibro-fatty degeneration of the conduction system, and using light microscopy, they were found to have nuclear membrane thinning, bubbling, and convolution throughout all areas sampled.
Lamin A/C-related cardiomyopathy is associated with sudden cardiac death early in the disease course, warranting early consideration of implantable cardioverter defibrillator implantation, and rapid progression to end-stage cardiomyopathy refractory to standard medical therapies, necessitating early referral to an advanced heart failure centre. We report a newly observed and recorded finding of morphologic nuclear alterations in late-stage disease using high-power light microscopy. These alterations underscore the pathophysiology of Lamin A/C-related cardiomyopathy and provide a basis for future research into disease-specific therapies.
核纤层蛋白A/C基因(LMNA)突变可导致心肌纤维化,表现为致心律失常性、心肌致密化不全或扩张型心肌病。纤维脂肪替代主要累及传导系统,传导疾病通常在收缩功能障碍之前出现。
两名年轻的、无血缘关系的白种男性,年龄分别为34岁和25岁,因晚期心力衰竭被转诊至我院治疗。两名患者的一级亲属均有心力衰竭和心源性猝死家族史,均被诊断为核纤层蛋白A/C突变,但在疾病发作前未进行筛查。尽管初始表型为扩张型心肌病和左心室心肌致密化不全,但两名患者的病情均迅速进展,出现室性心律失常、严重的左心室整体运动减弱,并依赖门诊米力农来完成日常生活活动。两名患者均在初次发病后2年内接受了心脏移植。切除心脏的手术病理显示传导系统存在纤维脂肪变性的特征性表现,并通过光学显微镜发现,在所有取样区域均有核膜变薄、起泡和卷曲现象。
核纤层蛋白A/C相关心肌病在疾病早期与心源性猝死相关,因此有必要早期考虑植入植入式心律转复除颤器,且该病会迅速进展为对标准药物治疗无效的终末期心肌病,因此需要早期转诊至晚期心力衰竭中心。我们报告了一项使用高倍光学显微镜在疾病晚期新观察并记录到的形态学核改变。这些改变强调了核纤层蛋白A/C相关心肌病的病理生理学,并为未来针对疾病特异性治疗的研究提供了基础。